Transient myeloproliferative disorder (transient leukemia) and hematologic manifestations of Down syndrome
- PMID: 10403079
Transient myeloproliferative disorder (transient leukemia) and hematologic manifestations of Down syndrome
Abstract
Transient Myeloproliferative Disorder (Transient Leukemia) is found in approximately 10% of newborn infants with Down Syndrome. It is characterized by the large numbers of megakaryoblasts in the peripheral blood, variable thrombocytopenia and, in a minority of cases, by a lethal course with hydrops fetalis or progressive hepatic fibrosis. Evidence is presented that this disease is truly leukemia, which, in most cases, recovers spontaneously. There is evidence that hematopoiesis is abnormal in Down Syndrome children who do not have leukemia. These abnormalities of red cells, platelets, and granulocytes are reviewed.
Similar articles
-
Hydrops fetalis in a neonate with down syndrome, transient myeloproliferative disorder and hepatic fibrosis.Fetal Pediatr Pathol. 2007 Sep-Dec;26(5-6):223-8. doi: 10.1080/15513810701818379. Fetal Pediatr Pathol. 2007. PMID: 18363154
-
Transient leukemia (transient myeloproliferative disorder, transient abnormal myelopoiesis) of Down syndrome.Adv Anat Pathol. 2006 Sep;13(5):256-62. doi: 10.1097/01.pap.0000213039.93328.44. Adv Anat Pathol. 2006. PMID: 16998319 Review.
-
Transient myeloproliferative syndrome/transient acute myeloid leukemia in a newborn with Down syndrome: a case report and literature review.Lab Hematol. 2003;9(1):38-41. Lab Hematol. 2003. PMID: 12661826 Review.
-
Hematological disorders in Down syndrome: ten-year experience at a Tertiary Care Centre in North India.Pediatr Hematol Oncol. 2005 Sep;22(6):507-12. doi: 10.1080/08880010591002350. Pediatr Hematol Oncol. 2005. PMID: 16169817
-
Down syndrome and leukemia--an overview of cytogenetic and molecular events.Turk J Pediatr. 1997 Oct-Dec;39(4):519-31. Turk J Pediatr. 1997. PMID: 9433155 Review. No abstract available.
Cited by
-
Life-threatening complications of transient abnormal myelopoiesis in neonates with Down syndrome.Eur J Pediatr. 2004 Jul;163(7):374-7. doi: 10.1007/s00431-004-1452-7. Epub 2004 Apr 28. Eur J Pediatr. 2004. PMID: 15138809
-
Modeling primitive and definitive erythropoiesis with induced pluripotent stem cells.Blood Adv. 2024 Mar 26;8(6):1449-1463. doi: 10.1182/bloodadvances.2023011708. Blood Adv. 2024. PMID: 38290102 Free PMC article.
-
Developmental differences in IFN signaling affect GATA1s-induced megakaryocyte hyperproliferation.J Clin Invest. 2013 Jul 1;123(8):3292-304. doi: 10.1172/JCI40609. Online ahead of print. J Clin Invest. 2013. PMID: 23863621 Free PMC article.
-
Some dynamic aspects of hematopoietic stem cells.Stem Cell Rev. 2008 Spring;4(1):57-64. doi: 10.1007/s12015-007-9007-8. Stem Cell Rev. 2008. PMID: 18176847
-
Transient myeloproliferative disorder and GATA1 mutation in neonates with and without Down syndrome.Indian J Pediatr. 2011 Jul;78(7):826-32. doi: 10.1007/s12098-010-0312-x. Epub 2011 Feb 2. Indian J Pediatr. 2011. PMID: 21287369
Publication types
MeSH terms
LinkOut - more resources
Medical